Back to Search
STEPHANIE COOK, D.O.
D.O.
Anesthesiology Physician
NPI: 1972997872IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
2020-03095(NC)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
OTHER
Class of 2015
Research & Publications (20)
Gastrointestinal side effects in chronic opioid users: results from a population-based survey.
PMID 18363893·Aliment Pharmacol Ther·2008
8-other
Development of a satellite-based hazard rating system for Dendroctonus frontallis (Coleoptera: Scolytidae) in the Ouachita Mountains of Arkansas.
PMID 17461062·J Econ Entomol·2007
7-preclinical
Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.
PMID 17374779·J Gen Virol·2007
7-preclinical
Effects of exercise load and blood-flow restriction on skeletal muscle function.
PMID 17909396·Med Sci Sports Exerc·2007
8-other
Avian- and mammalian-derived antibodies against adherence-associated proteins inhibit host cell colonization by Escherichia coli O157:H7.
PMID 17897225·J Appl Microbiol·2007
7-preclinical
Accelerometry as a measure of subject compliance in unilateral lower limb suspension.
PMID 16964746·Aviat Space Environ Med·2006
8-other
Redox balance mechanisms in Schistosoma mansoni rely on peroxiredoxins and albumin and implicate peroxiredoxins as novel drug targets.
PMID 16606626·J Biol Chem·2006
7-preclinical
Multiple sclerosis: pathologic, clinical, and imaging updates.
PMID 16596083·Rev Neurol Dis·2006
6-review
Updates in multiple sclerosis and related disorders: highlights of the 57th Annual Meeting of the American Academy of Neurology, April 9-16, 2005, Miami Beach, FL.
PMID 16400314·Rev Neurol Dis·2005
8-other
Symptomatic and disease-modifying therapies for multiple sclerosis: recent developments: highlights of the 9th Annual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis, October 3, 2004, Toronto, Ontario, Canada.
PMID 16400300·Rev Neurol Dis·2005
8-other
Advancing treatment with interferon beta-1b (Betaferon/Betaseron) in the next decade--thinking beyond the standard dose.
PMID 14712397·J Neurol·2003
6-review
Project IMPACT: results from a pilot validity study of a new observational database.
PMID 12483071·Crit Care Med·2002
4-observational
Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication.
PMID 12029150·J Gen Virol·2002
4-observational
Cell damage excites nociceptors through release of cytosolic ATP.
PMID 11790466·Pain·2002
7-preclinical
Differential responses of Equus caballus and Equus asinus to infection with two pathogenic strains of equine infectious anemia virus.
PMID 11230932·Vet Microbiol·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 509 BILTMORE AVE
ASHEVILLE, NC 28801 - Phone
- (347) 327-3242
Quick Facts
- NPI
- 1972997872
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile